Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients

Jablonowska Elzbieta; Pulik Piotr; Kalinowska Anna; Gasiorowski Jacek; Parczewski Milosz; Bociaga-Jasik Monika; Pulik Lukasz; Siwak Ewa; Wojcik Kamila

首页> 外文期刊>Journal of Medical Virology >Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients

【24h】

Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients

机译：基于Raltegravir和Ritonavir-Boosted Darunavir在HIV-1感染的治疗经验丰富的患者中的核苷 - 备用方案的疗效和安全性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aim: To assess the efficacy and tolerability of dual therapy containing raltegravir (RAL) and ritonavir boosted darunavir (DRV/r) in HIV-1-infected treatment-experienced patients.

机译：目的：评估含有RALTEGRAVIR（RAL）和Ritonavir的双重治疗的疗效和耐受性在HIV-1感染的治疗经验丰富的患者中促进Darunavir（DRV / R）。

著录项

来源
《Journal of Medical Virology》 |2017年第12期|共8页
作者
Jablonowska Elzbieta; Pulik Piotr; Kalinowska Anna; Gasiorowski Jacek; Parczewski Milosz; Bociaga-Jasik Monika; Pulik Lukasz; Siwak Ewa; Wojcik Kamila;
展开▼
作者单位

Med Univ Lodz Clin Infect Dis &

Hepatol Lodz Poland;

Hosp Infect Dis HIV Out Patient Clin Warsaw Poland;

Jagiellonian Univ Dept Infect Dis Med Coll Krakow Poland;

Wroclaw Med Univ Dept Infect Dis Hepatol &

Acquired Immune Deficie Wroclaw Poland;

Pomeranian Med Univ Dept Infect &

Trop Dis &

Immune Deficiency Szczecin Poland;

Jagiellonian Univ Dept Infect Dis Med Coll Krakow Poland;

Hosp Infect Dis HIV Out Patient Clin Warsaw Poland;

Hosp Infect Dis HIV Out Patient Clin Warsaw Poland;

Med Univ Lodz Clin Infect Dis &

Hepatol Lodz Poland;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学微生物学（病原细菌学、病原微生物学）;
关键词
ARV; DRV/r; dual therapy; HIV; kidney; lipids; RAL;

机译：ARV;DRV / R;双重治疗;艾滋病毒;肾脏;脂质;RAL;

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients [J] . Jablonowska Elzbieta, Pulik Piotr, Kalinowska Anna, Journal of Medical Virology . 2017,第12期

机译：基于Raltegravir和Ritonavir-Boosted Darunavir在HIV-1感染的治疗经验丰富的患者中的核苷 - 备用方案的疗效和安全性
2. Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial [J] . Sébastien Gallien, Joséphine Braun, Constance Delaugerre, Journal of Antimicrobial Chemotherapy . 2011,第9期

机译：raltegravir在治疗经验丰富的HIV-1感染患者中转用基于恩夫韦肽的治疗方案的疗效和安全性：EASIER ANRS 138随机试验的48周结果
3. Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial. [J] . Gallien S, Braun J, Delaugerre C, The Journal of Antimicrobial Chemotherapy . 2011,第9期

机译：raltegravir在治疗经验丰富的HIV-1感染患者中转用基于恩夫韦肽的治疗方案的疗效和安全性：EASIER ANRS 138随机试验的48周结果。
4. The clinical cohort study on prospective efficacy of CHD Therapeutic Regimen of “the regulation of Pi(Spleen) and protection of Xin(Heart)” method treating CHD patients [C] . Danping Xu, Xia Wang, Wenjie Luo, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：“ Pi（脾）的调节和心（心）的保护”法治疗冠心病的冠心病治疗方案前瞻性临床队列研究
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262) [O] . Babafemi Taiwo, Lu Zheng, Sebastien Gallien, -1

机译：Darunavir / Ritonavir Plus Raltegravir在治疗 - 幼稚HIV-1感染患者中的核苷 - 备件方案的疗效（Actg A5262）
7. Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial [O] . Sébastien Gallien, Joséphine Braun, Constance Delaugerre, 2011

机译：Raltegravir在治疗中的疗效和安全性 - 经验丰富的HIV-1感染患者从基于Enfuvirtide的方案切换的患者：随机化容易ANRS 138试验的48周结果

Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients

摘要

著录项

相似文献

相关主题

期刊订阅